Company Overview of Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, designs and develops insulin-based therapies for the treatment of diabetes in the United States. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals, Inc. was founded in 2004 and is based in Cleveland, Ohio.
10000 Cedar Avenue
Cleveland, OH 44106
Founded in 2004
Key Executives for Diasome Pharmaceuticals, Inc.
Similar Private Companies By Industry
|AlphaCore Pharma LLC||United States|
|Fabre-Kramer Pharmaceuticals, Inc.||United States|
|Smart Drug Systems Inc.||United States|
|Eisai Research Institute Of Boston, Inc.||United States|
|Mayne Pharma (USA), Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Philadelphia, PA | PwCPosted: Mar 19
- Harrisburg, PA | PwCPosted: Mar 19
- Chicago, IL | PwCPosted: Jan 06
- Los Angeles, CA | PwCPosted: Dec 19
Sponsored Financial Commentaries
To contact Diasome Pharmaceuticals, Inc., please visit www.diasome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.